Algo version: 0.98b
Getinge AB (publ) is listed at the OTC Exchange
Getinge AB (publ) [GNGBY]
OTC Sector: Healthcare Industry:Medical Devices

Is Getinge AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Getinge AB (publ) pays dividends. Last time was Tuesday 14th of May 2024 where the investors holding the stock on Tuesday 23rd of April 2024 were paid $0.24776 per share. Over the last 14 times between 2013 and 2024, Getinge AB (publ) has paid $1.10973449 with an average of $0.08 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Getinge AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $14.08, you would have made a profit of $7.13 per share or 50.64%

No, the average daily trading liquidity for Getinge AB (publ) is $16 937 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Getinge AB (publ) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.42, the company's ability to pay off the debt is normal. Getinge AB (publ) has a good net profit margin of 7.09% and should have high tolerances against inflation.

We have calculated the inflation risk for Getinge AB (publ) to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.